300314 戴维医疗
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)13.2839.5008.25215.2827.654
总资产报酬率 ROA (%)11.2398.0847.04213.0506.705
投入资产回报率 ROIC (%)12.8359.1727.98214.9607.654

边际利润分析
销售毛利率 (%)58.19558.55261.57258.63753.769
营业利润率 (%)27.71622.13518.39732.16420.207
息税前利润/营业总收入 (%)23.65917.80518.43632.10518.600
净利润/营业总收入 (%)23.87419.23916.91729.63717.414

收益指标分析
经营活动净收益/利润总额(%)88.26897.45678.79766.83077.987
价值变动净收益/利润总额(%)6.974-4.36119.12331.85924.503
营业外收支净额/利润总额(%)-3.092-0.084-0.039-0.784-3.158

偿债能力分析
流动比率 (X)5.0265.2255.2834.8435.079
速动比率 (X)4.2194.3854.4324.2154.401
资产负债率 (%)15.32715.45714.3060.15014.120
带息债务/全部投入资本 (%)1.5372.6332.2923.615-0.338
股东权益/带息债务 (%)6,336.4513,639.9624,244.9632,659.477-29,618.313
股东权益/负债合计 (%)552.428546.943599.012565.499608.205
利息保障倍数 (X)-7.335-4.130400.375167.528-18.821

营运能力分析
应收账款周转天数 (天)11.89611.67911.73312.89512.881
存货周转天数 (天)214.236245.152238.880184.544185.290